Molina Healthcare, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 6.83% in Molina Healthcare, Inc.
NYSE
Capital World Investors has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Molina Healthcare, Inc. common stock as of June 30, 2026.
NYSE
FMR LLC, through its subsidiaries, has reported a beneficial ownership of 3.6% of Molina Healthcare Inc.'s common stock as of June 30, 2026.
NYSE
AQR Capital Management, through its subsidiaries, has reported beneficial ownership of 5.5% of Molina Healthcare's common stock as of March 31, 2026.
NYSE
Vanguard Capital Management has reported beneficial ownership of 5.19% of Molina Healthcare Inc.'s common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.37% in Molina Healthcare Inc. as of March 31, 2026.
NYSE
T. Rowe Price Associates, Inc. has reported a 1.9% beneficial ownership stake in Molina Healthcare Inc. common stock as of December 31, 2025.
NYSE
AQR Capital Management, LLC and its parent entity have disclosed a beneficial ownership of 0.8% of Molina Healthcare, Inc.'s common stock as of December 31, 2025.
NYSE
FMR LLC and Abigail P. Johnson have reported a 5.8% beneficial ownership stake in Molina Healthcare Inc. as of December 31, 2025, held in the ordinary course of business.
NYSE
SCHEDULE 13G/A: BlackRock Amends Molina Healthcare Stake Disclosure
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 6.9% beneficial ownership stake in Molina Healthcare Inc. as of December 31, 2025.
NYSE
T. Rowe Price Associates, Inc. has reported a passive 6.5% beneficial ownership stake in Molina Healthcare Inc. as of September 30, 2025.
NYSE
AQR Capital Management, LLC and its parent company have reported a beneficial ownership of 5.41% in Molina Healthcare, Inc. common stock.
NYSE
T. Rowe Price Associates, Inc. has disclosed a 4.1% beneficial ownership stake in Molina Healthcare Inc. common stock as of June 30, 2025.
NYSE
Capital Research Global Investors has reduced its beneficial ownership in Molina Healthcare, Inc. to 4.0% of common stock.
NYSE
T. Rowe Price Associates, Inc. has reported a 7.0% beneficial ownership stake in Molina Healthcare Inc., holding 3,838,700 shares as of March 31, 2025.
NYSE
SCHEDULE 13G/A: T. Rowe Price Discloses 4.6% Stake in Molina Healthcare Inc.
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, disclosing a 4.6% beneficial ownership stake in Molina Healthcare Inc. as of December 31, 2024.